1
0
0
(1 - 35 from 49
)
Boehringer Ingelheim marks tenth anniversary of Spiriva
www.zenopa.com
Dr Marc Miravitlles, senior researcher at the department of pneumology at the Hospital Clinic in Barcelona, said: "COPD remains a debilitating, progressive and under-recognised lung disease and it is important that the most ...
Marc Miravitlles - touchRESPIRATORY
www.touchrespiratory.com
Marc Miravitlles is a pulmonologist working in clinical research in the Hospital Universitari Vall d’Hebron in Barcelona, Spain. His primary research interests include chronic obstructive pulmonary disease (COPD), chronic bronchitis, alpha-1-antitrypsin deficiency (AAT), …
Marc Miravitlles | Author | Microsoft Academicacademic.microsoft.com › author › publication
academic.microsoft.com
Summary Chronic obstructive pulmonary disease (COPD) is characterised by progressive airflow obstruction that is only partly reversible, inflammation in the ...
PLOS ONE: Testing for alpha-1 antitrypsin in COPD in outpatient...
journals.plos.org
Marc Miravitlles , ... Bernardino Alcázar Navarrete, José Miguel Rodríguez González- Moro, Marc Miravitlles, Miriam Barrecheguren, Manuel E.
Chronic Obstructive Pulmonary Disease Exacerbations - Google Books
books.google.ee
Chronic Obstructive Pulmonary Disease Exacerbations covers the definition, diagnosis, epidemiology, mechanisms, and treatment associated with COPD...
Asthma/COPD Overlap Syndrome (ACOS) Working Group Meeting
www.slideshare.net
... Keininger* • Megumi Kizawa* • JWH Kocks • Marek Kokot* • Jeannine Leuenberger* • Mark Milton-Edwards* • Marc Miravitlles • Karen Mezzi* ...
CiteSeerX — Gisbert R: Costs of chronic bronchitis and COPD: a 1-year...
citeseerx.ist.psu.edu
BibTeX @INPROCEEDINGS{Miravitlles_gisbertr:, author = {Marc Miravitlles and Md Cristina Murio and Md Tina Guerrero and Ramon Gisbert and Phd Dafne and Study …
Characterisation of the overlap COPD–asthma phenotype. Focus on ...www.sciencedirect.com › science › article › pii
www.sciencedirect.com
Marc Miravitlles has received speaker fees from Boehringer Ingelheim, Pfizer, AstraZeneca, Bayer Schering, Novartis, Talecris, Takeda-Nycomed, Merck, ...
Predictive value of control of COPD for risk of exacerbations - PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
Marc Miravitlles , Pawel Sliwinski , Chin Kook Rhee , Richard W Costello , Victoria Carter , Jessica H Y Tan , Therese S Lapperre , Bernardino Alcazar ...
The asthma-COPD overlap syndrome: a new entity? | COPD Research and...
copdrp.biomedcentral.com
Marc MiravitllesEmail author Marc Miravitlles has received speaker fees from Almirall, Boehringer Ingelheim, Pfizer, AstraZeneca, Chiesi, Esteve, ...
The overlap phenotype: the (missing) link between asthma and COPD |...
link.springer.com
(1); Marc Miravitlles · (2). Author Affiliations. 1. Institute of Respiratory Diseases and TB, University of Sassari, 21 Università Square...
The asthma-COPD overlap syndrome: a new entity? | SpringerLink
link.springer.com
Asthma and COPD are the most frequent chronic respiratory diseases. Although they have different characteristics, some individuals share features of both...
Leadership | Marc Miravitlles - COPD Home
www.copdforum.org
Place of work . Institut Clínic del Tòrax, Hospital Clinic Barcelona. Experience. Marc Miravitlles is a Chest Physician and Senior Researcher in the ...
Michael Baldwin - Google Scholar Citations
scholar.google.co.uk
16, Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective,... DLKDP Kevin Gruffydd-Jones , Guy Brusselle , Rupert Jones , Marc Miravitlles ... Primary care respiratory Medicine 26*,
Marc Miravitlles - Lebanese Pulmonary Societyslpsleb.org › tag › marc-miravitlles
slpsleb.org
The Treatment Algorithm of COPD – Marc Miravitlles · June 20, Paper presented at the Annual Meeting of the Lebanese Pulmonary Society – Phoenicia ...
A review of national guidelines for management of COPD in Europe |...
read.qxmd.com
Marc Miravitlles, Claus Vogelmeier, Nicolas Roche, David Halpin, João Cardoso, Alexander G Chuchalin, Hannu Kankaanranta, Thomas Sandström, Paweł Śliwiński ...
A new two-step algorithm for the treatment of COPD ...
erj.ersjournals.com
· A new two-step algorithm for the treatment of COPD Marc Miravitlles , Antonio Anzueto European Respiratory Journal Feb 2017, 49 (2) ; DOI:
(PDF) Chronic bronchial infection in COPD. Is there an infective...
www.academia.edu
Chronic bronchial infection in COPD. Is there an infective ... in Marc Miravitlles has received speaker fees from Boehringer patients with very severe ...
Diagnosis of alpha-1 antitrypsin deficiency: a population | COPD
www.dovepress.com
Diagnosis of alpha-1 antitrypsin deficiency: ... Diagnosis of alpha-1 antitrypsin deficiency: a population-based study ... Marc Miravitlles, ...
Health Economic Consequences of COPD Exacerbations - Taylor ...www.taylorfrancis.com › chapters › edit › health-economic-consequences-...
www.taylorfrancis.com
DOI link for Health Economic Consequences of COPD Exacerbations. Health Economic Consequences of COPD Exacerbations book. ByMarc Miravitlles.
Impact and prevention of severe exacerbations of COPD: a ...
www.dovepress.com
Impact and prevention of severe exacerbations of COPD: a review of the evidence David MG Halpin,1 Marc Miravitlles,2 Norbert Metzdorf,3 Bartolomé Celli4 1Department of Respiratory Medicine, Royal Devon and Exeter Hospital, Exeter, UK; 2Pneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain; 3Respiratory Medicine ...
Diagnosis of asthma–COPD overlap: the five commandments | European...
erj.ersjournals.com
Diagnosis of asthma–COPD overlap: the five commandments. Marc Miravitlles. European Respiratory Journal ... Marc Miravitlles. …
Caregivers’ burden in patients with COPD | COPD
www.dovepress.com
Caregivers’ burden in patients with COPD . Abstract; Fulltext; Metrics ... Marc Miravitlles, 1 Luz María Peña-Longobardo, 2 Juan Oliva-Moreno, 2 Álvaro Hidalgo ...
Speakers | Lung health | Monaco January,
www.lung-health.org
3rd International Workshop on Lung Health, Asthma & COPD: converging or diverging chronicity?
Treatment of COPD by clinical phenotypes: putting old evidence into...
erj.ersjournals.com
Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Marc Miravitlles, ... by clinical phenotypes: putting old evidence into ...
[Full text] The inevitable drift to triple therapy in COPD: an...
www.dovepress.com
The inevitable drift to triple therapy in David Price,4,5 Kevin Gruffydd-Jones,6 Marc Miravitlles,7 Dorothy L Keininger,8 Rebecca Stewart,5 Michael Baldwin ...
COPD Working Group - REGwww.regresearchnetwork.org › Working Groups / Committees
www.regresearchnetwork.org
Marc Miravitlles - Lead; Dermot Ryan; Richard Costello; Nicolas Roche; Alberto Papi; Juan José Soler; Faisal Yunus; Bernardino Alcazar Navarrete ...
Antibiotic treatment of exacerbations of COPD in general practice:...
www.dovepress.com
Peer reviewed article authored by (Marc Miravitlles, Carles Llor, Jesús Molina, et al). Read article or submit your manuscript for publishing.
Caring for patients with COPD and COVID-19: a viewpoint to spark ...cris.maastrichtuniversity.nl › publications › caring-for-patients-with-copd-a...
cris.maastrichtuniversity.nl
Sami O. Simons*, John R. Hurst, Marc Miravitlles, Frits M. E. Franssen, Daisy J. A. Janssen, Alberto Papi, Marieke L. Duiverman, Huib A. M. Kerstjens.
Difficulties in differential diagnosis of COPD and asthma in primary ...bjgp.org › content › tab-article-info
bjgp.org
Marc Miravitlles, Isabel Andreu, Yolanda Romero, Salvador Sitjar, Andreu Altés and Esther Anton. British Journal of General Practice 2012; 62 (595): e68-e
Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME...
www.dovepress.com
Claus F Vogelmeier,1 Kenneth R Chapman,2Marc Miravitlles,3 Nicolas Roche,4 Jørgen Vestbo,5 Chau Thach,6 Donald Banerji,6 Robert ...
Difficulties in differential diagnosis of COPD and asthma in primary...
bjgp.org
Marc Miravitlles has conducted the study supported by Boehringer Ingelheim and Pfizer and has received payments for speaking at scientific meetings and participating in advisory boards by the same companies. Esther Anton is a full time employee of Pfizer. The other authors have no conflict of interest to disclose.
Optimizing bronchodilation in the prevention of COPD exacerbationscyberleninka.org › article
cyberleninka.org
Similar topics of scientific paper in Economics and business , author of scholarly article — Marc Miravitlles, Antonio Anzueto, José R. Jardim.
All web results to the name "Marc Miravitlles"
sorted by relevance / date